COMPANY OVERVIEW

None

---

LOCATION

Hamilton, , Bermuda

New York, NY, USA

Altrincham, Cheshire, UK

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.sellaslifesciences.com/Home/default.aspx

---

CAREER WEBSITE

https://www.linkedin.com/company/3339909/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Apr 4, 2019

SELLAS Life Sciences Group and World-Renowned Cancer Center to Study Galinpepimut-S (GPS) in Combination with Nivolumab in Patients with Malignant Pleural Mesothelioma (MPM)

Dec 29, 2017

SELLAS Life Sciences Group Successfully Completes Business Combination with Galena Biopharma

Aug 8, 2017

Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group

May 2, 2016

SELLAS Life Sciences Group Announces Initiation of Galinpepimut-S (WT1 Cancer Vaccine) Phase 1 Clinical Trial in Combination with PD-1 Checkpoint Inhibitor for Patients with Ovarian Cancer

Apr 5, 2016

SELLAS Life Sciences Group Receives a Favorable Opinion for European Orphan Drug Designations for WT1 Cancer Vaccine (galinpepimut-S) for the Treatment of Acute Myeloid Leukemia and for Malignant Pleural Mesothelioma

For More Press Releases

---